RxDoctor Payments Data

Elizabeth Ukiri

Gerontology · Garland, TXNPI 1003331869

Payments from drug & device makers

$1,410in general payments, 2019–2025

Across 14 payments — averaging $100.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Teva Pharmaceuticals USA, Inc.$237
  • Sanofi$232
  • Boehringer Ingelheim$198
  • Medtronic$150
  • Kyowa Kirin, Inc.$140
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$139
  • plus $315 from 3 others

What the payments were for

  • Food & beverage$1,410100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,410 in reported general payments places this provider in the 75th percentile of 653 gerontology providers in Texas.

See all gerontology providers in Texas

Medicare billing

Part B allowed, 2024
$45,868
Medicare patients
43
Services billed
393

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban68$53,424
LokelmaSodium Zirconium Cyclosilicate14$23,179
JardianceEmpagliflozin13$18,018
EntrestoSacubitril/Valsartan17$16,067
TrulicityDulaglutide11$15,375
JanuviaSitagliptin Phosphate13$8,720
VascepaIcosapent Ethyl13$7,405
Gabapentin151$2,112
Atorvastatin Calcium139$1,179
NitrofurantoinNitrofurantoin Macrocrystal13$1,024
Diclofenac Sodium25$813
Nifedipine ErNifedipine17$734
Albuterol Sulfate HfaAlbuterol Sulfate23$688
AmantadineAmantadine Hcl20$655
Allopurinol15$625

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaLokelma$124$23,17914 claims
Boehringer IngelheimJardiance$198$18,01813 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 653 gerontology providers in Texas.

Other gerontology in Garland

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →